---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-018166"
form_type: "8-K"
ticker: "IMNN"
cik: "0000749647"
company_name: "Imunon, Inc."
filed_at: "2024-05-08T23:59:59+00:00"
generated_at: "2026-06-02T14:39:43.615799+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Imunon appoints Dr. Stacy R. Lindborg as President and CEO effective May 13

## Summary
- Employment agreement: $567,000 base salary, 100% target bonus, 225,000 stock options vesting over 4 years, $200,000 sign-on bonus.
- Dr. Lindborg brings 30 years of pharma/biotech experience; most recently co-CEO of BrainStorm Cell Therapeutics (BCLI).
- Phase 2 OVATION 2 topline results for IMNN-001 (ovarian cancer) expected by mid-summer; Phase 1 COVID-19 vaccine data by year-end.

## SEC filing metadata
- accession: 0001493152-24-018166
- form_type: 8-K
- ticker: IMNN
- cik: 0000749647
- company_name: Imunon, Inc.
- filed_at: 2024-05-08T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/749647/000149315224018166/0001493152-24-018166-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/749647/000149315224018166/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-018166
- JSON: https://secwatch.observer/filing/0001493152-24-018166.json
- Plain text: https://secwatch.observer/filing/0001493152-24-018166.txt

## Key facts
- Executive change
  Stacy R. Lindborg was appointed as President and Chief Executive Officer at Imunon, Inc..
  - Action: appointed
  - Role: President and Chief Executive Officer
  source text: On May 8, 2024, Imunon, Inc. (the “Company”) announced the appointment of Stacy R. Lindborg, Ph.D., as President and Chief Executive Officer of the Company, effective as of May 13, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/749647/000149315224018166/0001493152-24-018166-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.